circRNAs
circRNAs catalogs circular RNAs detected in human body fluids (plasma, serum, exosomes, urine) to support cancer biomarker discovery and liquid biopsy research.
Key Features:
- Database Content: Compiles circRNAs identified in plasma, serum, exosomes, and urine and records their reported expression and stability in these fluids.
- Cancer Biomarker Potential: Highlights differential circRNA expression between cancer patients and healthy individuals to facilitate selection of candidate biomarkers for diagnosis and monitoring via liquid biopsy.
- Pan-Cancer Dataset Integration: Synthesizes circRNA data across multiple cancer types to enable comparative and pan-cancer analyses of marker prevalence and specificity.
Scientific Applications:
- Cancer Diagnosis and Prognosis: Identification of circRNA candidates in body fluids for sensitive and specific liquid biopsy-based early detection and disease monitoring.
- Pan-Cancer Analysis: Comparative studies across cancer types to discover universal or tumor-type-specific circRNA markers.
Methodology:
Data derived from high-throughput transcriptome analysis of body fluids; the database synthesizes findings from a pan-cancer dataset to characterize the clinical relevance of circRNAs.
Topics
Details
- Added:
- 3/19/2021
- Last Updated:
- 4/26/2021
Operations
Publications
Wang S, Zhang K, Tan S, Xin J, Yuan Q, Xu H, Xu X, Liang Q, Christiani DC, Wang M, Liu L, Du M. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Molecular Cancer. 2021;20(1). doi:10.1186/s12943-020-01298-z. PMID:33430880. PMCID:PMC7798340.